Clinical Trials Directory

Trials / Conditions / Extrahepatic Cholangiocarcinoma

Extrahepatic Cholangiocarcinoma

13 registered clinical trials studyying Extrahepatic Cholangiocarcinoma — 6 currently recruiting.

StatusTrialSponsorPhase
RecruitingRepeated Endobiliary Radiofrequency Ablation Plus Durvalumab, Gemcitabine, and Cisplatin for Unresectable Extr
NCT07235007
Aichi Medical UniversityN/A
Not Yet RecruitingNeoadjuvant Gemcitabine and Cisplatin in Combination With Perioperative Pembrolizumab Versus Upfront Surgery f
NCT06923475
Amsterdam UMC, location VUmcPhase 2 / Phase 3
RecruitingDurvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma
NCT06440993
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestPhase 2
RecruitingLocally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)
NCT06101277
University of California, DavisN/A
Active Not RecruitingA Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid
NCT05712356
Lisata Therapeutics, Inc.Phase 2
RecruitingSafety and Efficacy of PDT vs RFA vs PDT+RFA for the Treatment of Extrahepatic Cholangiocarcinoma
NCT05519319
First People's Hospital of HangzhouN/A
UnknownAn Observational Real World Study on the Efficacy and Safety of Toripalimab Injection Combined With TACE in th
NCT05448183
Xuhua DuanPhase 2
TerminatedStudy of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract Cancer
NCT05009953
CSPC Ouyi Pharmaceutical Co., Ltd.Phase 2
UnknownSpyglass+RFA Versus Cytobrush+RFA for Extrahepatic Cholangiocarcinoma
NCT05233293
First People's Hospital of HangzhouN/A
TerminatedFeasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer
NCT04561453
University of Washington—
UnknownAdjuvant Immunotherapy Combined With Chemoradiation for Patients With High-risk reseCtable Extrahepatic chOlan
NCT04333927
Sun Yat-sen UniversityPhase 2
RecruitingA Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening
NCT07176962
Yingbin Liu, MD, PhD, FACS—
UnknownVEGF Signaling Promotes Cell Growth and Metastasis in Extrahepatic Cholangiocarcinoma in a VEGF Receptor Media
NCT02103179
First Affiliated Hospital, Sun Yat-Sen University—